Engineers from MIT and the Koch Institute will present new technologies for cancer diagnosis and drug development. The aim of the session is to stimulate new collaborations between MIT and the Koch Institute scientists and engineers with DF/HCC members. We have issued a new RFA this spring for the next round of Bridge funding, with applications due on September 5, 2013. Each team can request up to $750,000 over two years. Applications will be accepted from teams addressing unmet clinical needs in eight areas: Lung, pancreas, GBM, ovarian, melanoma, metastatic prostate cancer, metastatic breast cancer and adult leukemia.
Registration is required. Q+A and a networking reception will follow the presentations.
The Bridge Project Technology Seminar speakers include:
Linda Griffith, PhD, Member of the Koch Institute and Professor of Biological and Mechanical Engineering
Doug Lauffenburger, PhD, Member of the Koch Institute and Ford Professor of Biological Engineering, Chemical Engineering, and Biology
Ron Weiss, PhD, Associate Professor of Biological Engineering, MIT
Barbara Imperiali, PhD, Class of 1922 Professor of Chemistry and Professor of Biology, MIT
Peter So, PhD, Professor of Mechanical Engineering, and Biological Engineering, MIT
Joel Voldman, PhD, Associate Professor of Electrical Engineering and Computer Science, MIT
Krystyn van Vliet, PhD, Paul M. Cook Career Development Associate Professor of Materials Science and Engineering, MIT